Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multi Vessel Disease”

6,155 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,155 results

Early research (Phase 1)Study completedNCT01241292
What this trial is testing

Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 7
Not applicableStudy completedNCT00657436
What this trial is testing

Myeloid-Related Protein in Evaluation of Acute Chest Pain in the Emergency Departement

Who this might be right for
Myocardial IschemiaAcute Coronary SyndromeMyocardial Infarction+2 more
University of Zurich 403
Not applicableNot Yet RecruitingNCT06787807
What this trial is testing

Proteomic Analysis of Patients Undergoing Bariatric Surgery

Who this might be right for
ObesityColon CancerThyroid Cancer+14 more
Universidade Federal de Pernambuco 103
Early research (Phase 1)Study completedNCT04163107
What this trial is testing

Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Norwegian University of Science and Technology 19
Not applicableUnknownNCT04496011
What this trial is testing

Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation

Who this might be right for
FatigueLeukemiaLymphoma+2 more
Federal University of Health Science of Porto Alegre 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439136
What this trial is testing

Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Ended earlyNCT06304636
What this trial is testing

Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaRelapsed Multiple Myeloma
Cartesian Therapeutics 4
Early research (Phase 1)Active Not RecruitingNCT05363800
What this trial is testing

Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma

Who this might be right for
Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma
Jiangsu HengRui Medicine Co., Ltd. 74
Not applicableStudy completedNCT03955900
What this trial is testing

A Registry Study of Participants With Multiple Myeloma in Latin America

Who this might be right for
Multiple Myeloma
Janssen-Cilag Ltd. 2,059
Not applicableStudy completedNCT00716911
What this trial is testing

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 100
Early research (Phase 1)Not Yet RecruitingNCT06500507
What this trial is testing

QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Qilu Pharmaceutical Co., Ltd. 90
Large-scale testing (Phase 3)Study completedNCT00689936
What this trial is testing

Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 1,623
Not applicableStudy completedNCT03740971
What this trial is testing

Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke

Who this might be right for
Stroke
General Hospital of Shenyang Military Region 1,800
Post-approval studies (Phase 4)UnknownNCT01758536
What this trial is testing

Efficacy Study of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke

Who this might be right for
Ischemic Stroke
Huashan Hospital 1,100
Large-scale testing (Phase 3)Study completedNCT00465985
What this trial is testing

Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome

Who this might be right for
Muckle Wells Syndrome
Novartis 35
Testing effectiveness (Phase 2)Study completedNCT00618085
What this trial is testing

Motor Imagery Practice in Neurological Rehabilitation

Who this might be right for
StrokeBrain InjuryMultiple Sclerosis
Nuffield Orthopaedic Centre NHS Trust 50
Not applicableUnknownNCT01042717
What this trial is testing

Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection

Who this might be right for
Multiple MyelomaNon-Hodgkins Lymphoma
Shi, Patricia, M.D. 10
Testing effectiveness (Phase 2)Study completedNCT02336815
What this trial is testing

Selinexor Treatment of Refractory Myeloma

Who this might be right for
Multiple Myeloma
Karyopharm Therapeutics Inc 202
Testing effectiveness (Phase 2)Active Not RecruitingNCT06171685
What this trial is testing

MMRC Horizon One: RRMM (MMRC-099)

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Multiple Myeloma Research Consortium 300
Testing effectiveness (Phase 2)Study completedNCT01559935
What this trial is testing

Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Weill Medical College of Cornell University 74
Next Page